Updated December 4 2019
All research projects that include information and/or biological material from Janus Serum Bank must comply with the EU’s General Data Protection Regulation (GDPR). This means that the processing must have approval from the Regional Committee for Medical Research in Norway (REC). Furthermore, the processing needs legal basis according to GDPR Article 6 and 9. The applicant must have considered the need for a Data Protection Impact Assessment (DPIA) according to GDPR article 35. The applicant must prove that these requirements have been met before the data can be made available.Disclosure of information and/or biological material to countries outside the EU requires that the conditions in GDPR are met.
- Fill in the Application form in ELVIS, the metadatabase of the Cancer Registry of Norway.
- A detailed scientific protocol must be enclosed in the application, including background and goal of the study, method description, description of the data flow and a data analysis plan, description of the requested serum volume, power calculations, finance plan, a list of planned publications and Curriculum Vitae of the principal investigator.
- At least one collaborating partner/co-author from the Cancer Registry and /or Janus Serum Bank must be appointed.
- The application form and protocol is automatically sent to the Janus Serum Bank.
- The application will be processed by the steering group at Janus within four to six weeks after the application deadline.